We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Medison Recognized for Growth Leadership in Europe

By MedImaging staff writers
Posted on 09 Apr 2007
Medison Co., Ltd. More...
(Seoul, Korea), an industry-leading manufacturer of specialized diagnostic ultrasound systems, announced that the company has won the 2007 Frost & Sullivan Competitive Strategy Leadership Award in March 2007 in recognition of its strategic initiatives to establish itself as a leading enterprise in the European ultrasound market.

The award is presented each year to a company whose competitive strategy has yielded significant gains in market share during the research period.
"Medison has accomplished high growth in the world's biggest and most advanced market, Europe, by aggressive strategies and customer-oriented management,” said Karthik Arun B, head analyst from the Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company. "Especially it showed great accomplishment in the high-end 3D [three-dimensional] ultrasound system,” he added.

The company implemented an aggressive strategy to achieve a significant market share, especially in the high-end 3D ultrasound segment across Europe. Medison commands a market share of almost 40% in the high-end 3D and 4D ultrasound segment in Europe in 2006.

"Medison ultrasound systems are acknowledged for their superior quality and highly competitive prices. We believe this award reflects that,” said Jae-Bum Choi, CEO, Medison, "We will build on this foundation to globalize the company by creating a system of local headquarters.”

Eighty-five percent of Medison's sales come from exports. It has global networks all over the world. The company has 10 overseas subsidiaries and 100 agencies in 90 countries. The local headquarters system will be introduced gradually by 2010. As a first step, Medison has established a European headquarters in Hoofddorp, the Netherlands in 2006.

Medison has emerged as a very important participant in the ultrasound market. The company has been successful in a market dominated by established multi-modality vendors. It has an aggressive pricing strategy and provides a top-of-the-line product range at highly competitive prices.

Medison, also winner of the Frost & Sullivan Product Differentiation & Innovation Award in 2001, was recognized as ‘The Highest Growth Rate Enterprise' by the ultrasound system market report ‘Klein Report' in 2004, recording a 94% growth rate in the U.S. market.


Related Links:
Medison
Frost & Sullivan

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Pulmonary Ventilator
OXYMAG
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.